title: Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.
abstract: α-Hemolysin (HlyA) from Escherichia coli and leukotoxin A (LtxA) from Aggregatibacter actinomycetemcomitans are important virulence factors in ascending urinary tract infections and aggressive periodontitis, respectively. The extracellular signaling molecule ATP is released immediately after insertion of the toxins into plasma membranes and, via P2X receptors, is essential for the erythrocyte damage inflicted by these toxins. Moreover, ATP signaling is required for the ensuing recognition and phagocytosis of damaged erythrocytes by the monocytic cell line THP-1. Here, we investigate how these toxins affect THP-1 monocyte function. We demonstrate that both toxins trigger early ATP release and a following increase in the intracellular Ca2+concentration ([Ca2+]i) in THP-1 monocytes. The HlyA- and LtxA-induced [Ca2+]iresponse is diminished by the P2 receptor antagonist in a pattern that fits the functional P2 receptor expression in these cells. Both toxins are capable of lysing THP-1 cells, with LtxA being more aggressive. Either desensitization or blockage of P2X1, P2X4, or P2X7receptors markedly reduces toxin-induced cytolysis. This pattern is paralleled in freshly isolated human monocytes from healthy volunteers. Interestingly, only a minor fraction of the toxin-damaged THP-1 monocytes eventually lyse. P2X7receptor inhibition generally prevents cell damage, except from a distinct cell shrinkage that prevails in response to the toxins. Moreover, we find that preexposure to HlyA preserves the capacity of THP-1 monocytes to phagocytose damaged erythrocytes and may induce readiness to discriminate between damaged and healthy erythrocytes. These findings suggest a new pharmacological target for protecting monocytes during exposure to pore-forming cytolysins during infection or injury.
authors.affiliation: MEMBRANES, Department of Biomedicine, Aarhus University, Aarhus C, Denmark.
authors.forename: Steen K
authors.identifier: http://orcid.org/0000-0001-5846-0155
authors.initials: SK
authors.lastname: Fagerberg
authors.affiliation: MEMBRANES, Department of Biomedicine, Aarhus University, Aarhus C, Denmark.
authors.forename: Martin R
authors.identifier: http://orcid.org/0000-0001-8847-9201
authors.initials: MR
authors.lastname: Jakobsen
authors.affiliation: MEMBRANES, Department of Biomedicine, Aarhus University, Aarhus C, Denmark.
authors.forename: Marianne
authors.initials: M
authors.lastname: Skals
authors.affiliation: MEMBRANES, Department of Biomedicine, Aarhus University, Aarhus C, Denmark hp@biomed.au.dk.
authors.forename: Helle A
authors.initials: HA
authors.lastname: Praetorius
mesh_terms: D016976:Aggregatibacter actinomycetemcomitans / Q000378:metabolism*; D001427:Bacterial Toxins / Q000378:metabolism / Q000633:toxicity*; D016923:Cell Death / Q000187:drug effects; D003593:Cytoplasm / Q000378:metabolism; D003603:Cytotoxins / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism; D004926:Escherichia coli / Q000378:metabolism*; D029968:Escherichia coli Proteins / Q000378:metabolism / Q000633:toxicity; D005098:Exotoxins / Q000378:metabolism / Q000633:toxicity; D006460:Hemolysin Proteins / Q000378:metabolism / Q000633:toxicity*; D006461:Hemolysis / Q000502:physiology; D006801:Humans; D009000:Monocytes / Q000187:drug effects* / Q000378:metabolism; D058469:Receptors, Purinergic P2X / Q000502:physiology*
chemical_list: D001427:Bacterial Toxins; D003603:Cytotoxins; D029968:Escherichia coli Proteins; D005098:Exotoxins; D006460:Hemolysin Proteins; D058469:Receptors, Purinergic P2X; C018579:leukotoxin